期刊文献+

可溶性CD40L促进甲状腺相关性眼病患者眼眶成纤维细胞增殖和透明质酸合成酶表达 被引量:3

Soluble CD40L promotes proliferation of orbital fibroblasts and expression of hyaluronan synthase in patients with thyroid associated ophthalmopathy
下载PDF
导出
摘要 目的 探讨可溶性CD40L(sCD40L)对甲状腺相关性眼病(TAO)患者眼眶成纤维细胞(OFs)增殖和3种透明质酸合成酶(HAS)mRNA表达水平的影响,初步探讨sCD40L在TAO发病中的作用。方法 取5例TAO患者和3例正常对照标本原代培养OFs,采用MTS比色法检测终质量浓度6.25、12.5、25、50、100、200ng/mL的sCD40L作用48h后对不同来源OFs增殖的影响;实时荧光定量PCR技术检测终质量浓度12.5、25、50、100ng/mL及作用3、6、12、24h后的sCD40L对不同来源OFs的3种HAS基因(HAS1~3)表达水平的影响。结果 25ng/mL及以上浓度的sCD40L作用48h后对TAO患者OFs有促增殖作用(P〈0.05);而50ng/mL及以上浓度的sCD40L作用48h后才能对正常对照OFs有促增殖作用(P〈0.05),且作用较弱。TAO患者OFs中HAS3mRNA的合成在sCD40L的刺激下增加,并且呈现出浓度和时间依赖的趋势。结论 sCD40L能够促进TAO患者OFs的生长以及HAS3基因的表达,提示sCD40L在TAO的病理过程中起一定作用。 Objective To investigate the effects of soluble CD40L(sCD40L)on proliferation of orbital fibroblasts(OFs)and the expression of three types of hyaluronan synthase(HAS)in vitro,so as to explore the role of sCD40 Lin the pathogenesis of thyroid-associated ophthalmopathy(TAO).Methods OFs obtained from 5patients with TAO and 3normal controls were primarily culutred.The effect of different concentrations of sCD40L(6.25,12.5,25,50,100 and 200ng/mL)on proliferation of OFs of different sources were examined by MTS after 48 hexposure.OFs were also cultured with different concentrations of sCD40L(12.5,25,50 and 100ng/mL)for 3,6,12 and 24h,and then the expression levels of HAS1-3mRNA were determined by real-time RT-PCR.Results Treatment with sCD40 Lat concentrations higher than 25ng/mL for 48 h obviously promoted the proliferation of OFs in patients with TAO(P〈0.05).In contrast,treatment with sCD40 Lonly at concentrations higher than 50ng/mL for 48 hcould promote proliferation of OFs from normal control,and the effect was comparatively weak.HAS3 mRNA expression of OFs in TAO patients was increased after exposed to sCD40L(P〈0.05),and the increase was in a concentration-and time-dependent manner.Conclusion sCD40 Lcan promote the proliferation of OFs and expression of HAS3 mRNA in patients with TAO,which implies that sCD40 Lplays an important role in the pathogenesis of TAO.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2015年第10期1138-1142,共5页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(81371056)~~
关键词 可溶性CD40配体 GRAVES眼病 眼眶成纤维细胞 透明质酸合成酶 soluble CD40ligand Graves ophthalmopathy orbital fibroblasts hyaluronan synthase
  • 相关文献

参考文献14

  • 1Bahn R S. Graves' ophthalmopathy[J].N Engl J Med,2010, 362: 726-738.
  • 2Hwang C J, Afifiyan N, Sand D, Naik V, Said J, Pollock S J, et al.Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1[J]. Invest Ophthalmol Vis Sci, 2009, 50: 2262-2268.
  • 3Sempowski G D, Rozenblit J, Smith T J, Phipps R P. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production[J]. Am J Physiol, 1998, 274(3 Pt 1): C707-C714.
  • 4Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, et al.Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model[J]. J Invest Dermatol, 2006, 126: 105-113.
  • 5Gillespie E F, Raychaudhuri N, Papageorgiou K I, Atkins S J, Lu Y, Charara L K,et al.Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB[J]. Invest Ophthalmol Vis Sci, 2012, 53: 7746-7753.
  • 6Mys ' liwiec J, Waligórski D, Niko?ajuk A, Górska M.Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy[J]. Adv Med Sci, 2007, 52: 104-108.
  • 7Pietravalle F, Lecoanet-Henchoz S, Blasey H, Aubry J P, Elson G, Edgerton M D, et al.Human native soluble CD40L is a biologically active trimer, processed inside microsomes[J]. J Biol Chem, 1996, 271: 5965-5967.
  • 8Pappa A, Jackson P, Stone J, Munro P, Fells P, Pennock C, et al.An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy[J]. Eye (Lond), 1998, 12 ( Pt 2): 237-244.
  • 9Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M,et al.Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties[J]. J Biol Chem, 1999, 274: 25085-25092.
  • 10Kaback L A, Smith T J. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy[J].J Clin Endocrinol Metab, 1999, 84: 4079-4084.

二级参考文献31

  • 1Prabhakar B S,Bahn R S,Smith T J,et al.Current perspectve on the pathogenesis ofGraves' disease and ophthalmopathy.Endocr Rev,2003,24(6):802-835.
  • 2Pappa A,Jackson P,Stone J,et al.An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy.Eye(Lond),1998,12(2):237-244.
  • 3Martins J R,Furlanetto R P,Oliveira L M,et al.Comparison of practical methods for urinaryglycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy.Clin Endocrinol (Oxf),2004,60 (6):726-733.
  • 4Smith T J,Hoa N.Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen,insulin-like growth factor-I receptor.J Clin Endocrinol Metab,2004,89(10):5076-5080.
  • 5EI-Kaissi S,Frauman A G,Wall J R.Thyroid-associated ophthalmopathy:a practical guide to classification,natural history and management.Intern Med J,2004,34(8):482-491.
  • 6Li Y, Rahmanian M, Widstrom C, Lepperdinger G, Frost G I, Heldin P. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types Ⅰ and Ⅲ collagen gene expression [J]. Am J Respir Cell Mol Biol, 2000,23: 411-418.
  • 7Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y. Graves' ophthalmopathy: epidemiology and natural history[J]. Intern Med, 2014,53 : 353-360.
  • 8Bahn R S. Graves' ophthalmopathy[J]. N Engl J Med, 2010,362: 726-738.
  • 9Prabhakar B S, Bahn R S, Smith T J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy[J]. Endocr Rev, 2003,24 : 802-835.
  • 10Bonaque J C, Pascual-Figal D A, Manzano-Ferndndez S, Gonzdlez-Cdnovas C, Vidal A, Mufioz-Esparza C, et al. Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure[J]. Rev Esp Cardiol (Engl Ed), 2012,65: 606-612.

共引文献9

同被引文献24

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部